Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOLIFE SOLUTIONS INC Director's Dealing 2020

Jun 4, 2020

32106_dirs_2020-06-03_d857a048-5933-45c9-af9b-5e5598f4699a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOLIFE SOLUTIONS INC (BLFS)
CIK: 0000834365
Period of Report: 2019-01-17

Reporting Person: GIRSCHWEILER THOMAS (Director, 10% Owner)
Reporting Person: Taurus4757 GmbH (10% Owner)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-01-17 Common Stock M 10714 $1.261 Acquired 1535391 Indirect
2019-10-04 Common Stock S 162760 $15.36 Disposed 1372631 Indirect
2020-05-13 Common Stock X 1544194 $4.75 Acquired 2916825 Indirect
2020-05-13 Common Stock S 492277 $14.90 Disposed 2424548 Indirect
2020-05-22 Common Stock S 476191 $10.50 Disposed 1948357 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-01-17 Stock Option (Right to Buy) $1.261 M 10714 Disposed 2019-02-26 Common Stock (10714) Direct
2020-05-13 Warrants (Right to Buy) $4.75 X 1544194 Disposed 2021-03-25 Common Stock (1544194) Indirect

Footnotes

F1: The shares of common stock, par value $0.001 per share (the "Common Stock") were issued to Taurus457 GmbH ("Taurus"), an entity wholly owned by Thomas Girschweiler (together with Taurus, the "reporting person") a director and 10% shareholder of Biolife Solutions, Inc. (the "Company"), upon exercise of the warrants held by the reporting person.

F2: On May 13, 2020, the reporting person exercised an in-the-money warrant to purchase 1,544,194 shares of Common Stock of the Company for $4.75 per share pursuant to Rule 16b-6 under the Securities Exchange Act of 1934, as amended. The reporting person exercised the warrant on a cashless basis pursuant to the terms of the warrant, resulting in the Company's withholding of 492,277 of the warrant shares to pay the exercise price and issuing to the reporting person the remaining 1,051,197 shares.

F3: The warrants were issued to Taurus in March 2014 in connection with conversion of outstanding promissory notes and interest accrued thereon for units consisting of common stock and warrants.